We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App





Bioperfectus SARS-CoV-2 Antigen Rapid Test Kit with High Sensitivity and Specificity Assists in Fight against COVID-19 Pandemic

By HospiMedica International staff writers
Posted on 12 Mar 2021
Print article
Image: Bioperfectus Novel Corona Virus (SARS-CoV-2) Antigen Rapid Test Kit (Photo courtesy of Jiangsu Bioperfectus Technologies Co., Ltd.)
Image: Bioperfectus Novel Corona Virus (SARS-CoV-2) Antigen Rapid Test Kit (Photo courtesy of Jiangsu Bioperfectus Technologies Co., Ltd.)
Jiangsu Bioperfectus Technologies Co., Ltd.’s (Shanghai, China) Novel Corona Virus (SARS-CoV-2) Antigen Rapid Test Kit with clinically proven high sensitivity and specificity is playing an important role in COVID-19 diagnostics as a fast and cost-efficient antigen test.

While the reverse transcription real-time polymerase chain reaction (RT-PCR) assay, which is a nucleic acid amplification test (NAAT), remains the “gold standard” for COVID-19 diagnosis, rapid antigen tests, which detect the presence of viral proteins (antigens) are proving to be a faster and cheaper way for communities to detect ongoing infection. Despite their growing demand, there has been a shortage of COVID-19 rapid antigen tests in Europe due to the heavy reliance of EU countries on rapid antigen tests as a surplus testing option through the next phase of the pandemic, slow pace of vaccination, and a comparatively weak supply chain.

Bioperfectus Novel Corona Virus (SARS-CoV-2) Antigen Rapid Test Kit with its clinical proven accuracy is helping healthcare workers to quickly find out whether someone is currently at risk of spreading the disease, which will effectively curb the further spread of the virus. Bioperfectus COVID-19 rapid antigen test has been clinically proven to have high sensitivity of 96.7% and specificity of 97.9% by several institutes worldwide. Additionally, in a recent evaluation performed by the UK Department of Health and Social Care, Bioperfectus COVID-19 rapid antigen test showed no drop off in sensitivity when compared with the wild type with respect to the following variants - VOC1 Kent, UK, B.1.1.7 and VOC2 South Africa, B.1.351.

Bioperfectus Novel Corona Virus (SARS-CoV-2) Ag Rapid Test offers nasal, nasopharyngeal and oropharyngeal swab in both sterile tube and sterile peel-down pouch packages to meet the varied testing demands in different clinical laboratories across the world. Bioperfectus COVID-19 rapid antigen test also offers additional advantages such as fast results within 15 minutes, easy three-step use, swab with optional protective jacket to avoid biohazard, quality control for reliable results, and inclusion of all necessary components in the kit.

Related Links:
Jiangsu Bioperfectus Technologies Co., Ltd.

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
Medical-Grade POC Terminal
POC-821
New
Phototherapy Eye Protector
EyeMax2

Print article

Channels

Surgical Techniques

view channel
Image: The surgical team and the Edge Multi-Port Endoscopic Surgical Robot MP1000 surgical system (Photo courtesy of Wei Zhang)

Endoscopic Surgical System Enables Remote Robot-Assisted Laparoscopic Hysterectomy

Telemedicine enables patients in remote areas to access consultations and treatments, overcoming challenges related to the uneven distribution and availability of medical resources. However, the execution... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.